Next Article in Journal
Utilization of Multiparametric MRI of Prostate in Patients under Consideration for or Already in Active Surveillance: Correlation with Imaging Guided Target Biopsy
Previous Article in Journal
Plasma Osteopontin Levels is Associated with Biochemical Markers of Kidney Injury in Patients with Leptospirosis
Open AccessEditorial

COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers

Department of Surgery, Vascular Disease Centre University Hospital of Ferrara, 44124 Cona, Italy
Diagnostics 2020, 10(7), 440; https://doi.org/10.3390/diagnostics10070440
Received: 9 June 2020 / Revised: 25 June 2020 / Accepted: 26 June 2020 / Published: 29 June 2020
(This article belongs to the Special Issue Biomarkers of Vascular Diseases)
COVID-19, a disease initially thought to be prominently an interstitial pneumonia with varying degrees of severity, can be considered a vascular disease with regards to serious complications and causes of mortality. Quite recently, blood clots have emerged as the common factor unifying many of the symptoms initially attributed without an explanation to COVID-19. Cardiovascular biomarkers and particularly, D-dimer and troponin appear to be very powerful prognostic markers, signaling the need for earlier and more aggressive interventions and treatments in order to avoid and/or minimize arterial/venous thromboembolism and myocardial infarct. The ultrasound imaging patterns at both the lung and peripheral vascular level can also be very useful weapons that have the advantage of being able to monitor longitudinally the clinical picture, something that real-time PCR/nasopharyngeal swab is not able to do and that CT can only pursue with significant radiation exposure. A lesson learned in the early phase of the COVID-19 pandemic suggests quitting and starting again with targeted imaging and blood vascular biomarkers. View Full-Text
Keywords: COVID-19; SARS-CoV-2; thrombosis; deep vein thrombosis; venous thromboembolism; ultrasound; vascular biomarkers; D-dimer; ischemia; lung ultrasound; contrast-enhanced ultrasound; pulmonary embolism COVID-19; SARS-CoV-2; thrombosis; deep vein thrombosis; venous thromboembolism; ultrasound; vascular biomarkers; D-dimer; ischemia; lung ultrasound; contrast-enhanced ultrasound; pulmonary embolism
Show Figures

Figure 1

MDPI and ACS Style

Zamboni, P. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers. Diagnostics 2020, 10, 440.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop